Search

everythinglearnresearchcommunity

for

Search:↓

Cyclosporin A and FK506 can start new hair growth without needing immunosuppression.

Disrupting the Flcn gene in mice causes early kidney cysts and tumors, which can be treated with rapamycin.

Using the drugs AMD3100 and Tacrolimus together greatly improves skin healing and hair growth after a deep skin cut by increasing stem cells in the wound.

Soymetide-4 from soy can prevent hair loss caused by a cancer drug in rats.

Low-dose oral minoxidil combined with topical minoxidil improves hair density in breast cancer patients but may cause excess hair growth.

A new method helps manage skin side effects from hormonal cancer therapy, improving patient care.

BBR-SA nanomedicine is a safe and effective treatment for breast cancer.

Matriptase imbalance contributes to cancer development and spread.

The peptide IMT-P8 can effectively deliver proteins into the skin and cells for potential skin treatments.

Photodynamic therapy successfully treated skin cancer in a 53-year-old woman.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

The compounded topical solution is safe, stable, and effective for personalized alopecia treatment.

The method could improve vitiligo treatment by effectively delivering therapy to hair follicles.

Blocking mTORC1 activity with rapamycin could help increase hair pigmentation and growth, potentially reversing gray hair.

Microneedles improve drug delivery for skin diseases, enhancing treatment effectiveness and patient compliance.

FA-MNPs effectively targeted and killed cancer cells but didn't overcome drug resistance.

Targeting ornithine decarboxylase can help prevent skin cancer.

Blocking miR-27a increases sheep hair follicle stem cell growth and decreases cell death, which could help improve wool quality and treat hair loss.

The nanohybrid system significantly improved wound healing and showed strong antibacterial activity.

Research on non-muscle invasive bladder cancer has increased, with the U.S. leading, and highlights effective treatments like BCG despite some side effects.

Tumor-targeted drug carriers can improve chemotherapy precision and reduce side effects.

Tianeptine, an antidepressant, may prevent stress-induced hair loss in mice.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.

Targeting multiple pathways and understanding genetic mutations are crucial for effective melanoma therapy.

Topical vitamin D3 does not prevent hair loss from chemotherapy.

Germacrene analogs, especially 8-Hydroxy germacrene B, are more effective than germacrone at blocking a hormone-related enzyme and could help treat hair loss.

A new 3D breast tumor model helps test drug effects more accurately than traditional methods.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.